UBS Group’s Langar Global HealthTech ETF LGHT Stock Holding History

UBS Group’s Portfolio LGHT Stock Details LGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.89K	Buy	1,158 +568	+96%	+$4.76K	﹤0.01%	8584
2026 Q1	$5.13K	Sell	590 -113	-16%	-$1.09K	﹤0.01%	8833
2025 Q4	$7.03K	Buy	703 +201	+40%	+$2.04K	﹤0.01%	8485
2025 Q3	$5.05K	Buy	502 +413	+464%	+$4.25K	﹤0.01%	8902
2025 Q2	$927	Buy	+89	New	+$882	﹤0.01%	9706
2025 Q1	–	Sell	-212	Closed	-$2.15K	–	10506
2024 Q4	$2.15K	Buy	+212	New	+$2.22K	﹤0.01%	9101
2024 Q3	–	Sell	-10	Closed	-$103	–	9820
2024 Q2	$103	Buy	+10	New	+$104	﹤0.01%	9157

Other funds holding LGHT

INVST Indianapolis, Indiana $1.03B AUM 29.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's LGHT Position: Q2 2026 in Review

UBS Group increased its Langar Global HealthTech ETF (LGHT) stake by 96% in Q2 2026, buying an estimated $4.76K and bringing the position to 1,158 shares worth $9.89K. The position accounts for ﹤0.01% of the portfolio, ranked #8584.

UBS Group first reported a position in LGHT in Q2 2024 and has held it in 7 quarters since. 3 funds tracked by Wall St. Rank hold LGHT as of Q2 2026.

UBS Group held 1,158 shares of Langar Global HealthTech ETF worth $9.89K as of Q2 2026.
UBS Group bought 568 Langar Global HealthTech ETF shares in Q2 2026, an estimated $4.76K.
Langar Global HealthTech ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8584 holding.
UBS Group first reported a position in Langar Global HealthTech ETF in Q2 2024 and has held it in 7 quarters since.
3 funds tracked by Wall St. Rank held Langar Global HealthTech ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.